Benzimidazole-Opioids (Nitazenes)
The DEA’s report on benzimidazole-opioids (Nitazenes) highlights the rising abuse of synthetic opioids from this structural class, which have been linked to numerous toxicology cases and deaths since 2019. These substances, which act as mu-opioid receptor agonists, pose significant public health risks due to their potency and lack of medical use in the United States. Their presence in the illicit drug market underscores the ongoing opioid epidemic and the dangers of emerging synthetic drugs.